Prof Bernard Allaouchiche

Critical care — Hospices Civils de Lyon, France

LeadR Profile

Prof Bernard Allaouchiche Hospices Civils de Lyon France
1 394 ScienceLeadR Reputation 1394
Network Map

Critical care

Subspecialties: Veterinary Medicine - Anesthesiology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1993 - 2026

Source: PubMed

Hospices Civils de Lyon

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 421

Citations

Citations: 15 017 1st author: 21 Last author: 100 Unique author: 4


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
PARTNER: Nurse Participation and Professional Experience During Family Conferences in Intensive Care: A Qualitative Study.
trust, nurses, communication, physicians, intensive care units
Nurs Crit Care20260
Targeting capillary leak in experimental sepsis and endotoxemia: a systematic review of therapeutic agents, methods and models in animal studies.
bias, endotoxemia, capillaries, sepsis, therapeutics
Crit Care20260
ONCOTHO-ICU : Survival prognostic factors among lung cancer patients admitted to ICU between 2021 and 2023.
lung, respiratory tract diseases, neoplasms, lung neoplasms, intensive care units, prognosis
Respir Med20260
Prevention and diagnosis of ventilator-associated pneumonia, what you should know, what is debated and what should come next.
anesthesia, pneumonia, ventilator-associated, pneumonia, diagnosis, therapeutics, infections
Anaesth Crit Care Pain Med20260
Delayed intubation and 60-day mortality in severe COVID-19-associated acute respiratory failure in an emulated target trial using the OUTCOMEREA network.
intubation, mortality, covid-19, pneumonia, intensive care units
Sci Rep20260

Clinical Studies 29

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4 Study Chair: 3

By phase:

N/A 18
Phase 3 6
Phase 4 2
Phase 1/Phase 2 1
Phase 2 1
Phase 2/Phase 3 1

By status:

Completed 18
Recruiting 5
Unknown 4
Terminated 2

By type:

Interventional 20
Observational 9

By Monocentric/Multicentric:

monocentric 13
multicentric2to4 7
multicentric5to9 2
multicentricup10 7

Main Topics

Cohort/Consortium Investigators 15

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Comparison of Landiolol versus standard of care for prevention of mortality in patients hospitalized for a septic shock with hypercontractlity an open label prospective randomized study
2024-518251-31-00 — mortality, shock, septic
Phase 3Recruiting2024
Labile Iron Removal by Adding the Iron Chelator MEX CD1 to Dialysate in Sepsis Associated Acute Kidney Injury
NCT07236463 — continuous renal replacement therapy, pilot projects, chelating agents, pilots, safety, blood, iron chelating agents, kidney, sepsis, therapeutics, intensive care units, renal replacement therapy, jugular veins, blood circulation, veins, membranes, acute kidney injury, dialysis solutions, catheters
Phase 1/Phase 2Recruiting2026
Feasibility Trial of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or Myelofibrosis
NCT06781099 — myelodysplastic syndromes, solutions, chelation therapy, iron overload, therapeutics, outpatients, primary myelofibrosis, dialysis solutions
N/ARecruiting2026
Rhu pGSN for Acute Respiratory Distress Syndrome (ARDS)
NCT05947955 — safety, saline solution, administration, intravenous, solutions, respiratory insufficiency, pneumonia, body weight, therapeutics, gelsolin, respiratory distress syndrome, infections, plasma
Phase 2Recruiting2024
Observed Pharmacokinetic of Piperacillin Tazobactam Compared to Amikacin in ICU
NCT03990467 — toxemia, piperacillin, tazobactam drug combination, shock, septic, pharmaceutical preparations, systemic inflammatory response syndrome, drug monitoring, piperacillin, tazobactam, sepsis, amikacin, therapeutics, intensive care units, plasma
N/ARecruiting2021

LeadR Networks

Main global connection map